Welcome to CKB CORE's new home! Please be sure to update any bookmarks you may have.
×

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01106898
Title Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Treating Women With Stage I or Stage II Breast Cancer Who Have Undergone Surgery
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Nebraska
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.